Inventor
MAY PAUL D
US15 patents
⚠️ This page may combine multiple inventors who share the name “MAY PAUL D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UPJOHN CO
7 patentsUS5866589AFeb 2, 1999
Alkyl substituted piperadinyl and piperazinyl anti-AIDS compounds
UPJOHN CO47 citations92
US7119209B2Oct 10, 2006
Process for preparing indolinone derivatives
UPJOHN CO17 citations82
US6274580B1Aug 14, 2001
Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
UPJOHN CO4 citations73
US6184216B1Feb 6, 2001
Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
UPJOHN CO4 citations73
US6177453B1Jan 23, 2001
Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
UPJOHN CO4 citations73
US5955617ASep 21, 1999
Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
UPJOHN CO7 citations73
US6353023B1Mar 5, 2002
Inhibitors of protein tyrosine phosphatase
UPJOHN CO5 citations60
ABBOTT LAB
4 patentsUS5340802AAug 23, 1994
Peptide analog type-B CCK receptor ligands
ABBOTT LAB47 citations91
US5120749AJun 9, 1992
Platelet activating antagonists
ABBOTT LAB5 citations62
US5382670AJan 17, 1995
Platelet activating factor antagonists
ABBOTT LAB4 citations61
US5120751AJun 9, 1992
Benzoylphenyl pyridinylthiazolidine compounds as platelet activating antagonists
ABBOTT LAB1 citations50
(unassigned)
3 patentsUS5994577ANov 30, 1999
Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
21 citations91
US6410585B1Jun 25, 2002
Inhibitors of protein tyrosine phosphatase
36 citations89
US6329545B1Dec 11, 2001
Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
14 citations72